Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Paliperidone Palmitate vs. Oral Risperidone in First-Episode Schizophrenia
NCT01451736Phase 4Completed
- Sponsor
- University of California, Los Angeles
- Start
- Oct 2011
- Primary completion
- Dec 2021
- Modality
- Metabolically Activated Prodrugs
- Countries
- 1
01
Overview
A Phase 4 trial of paliperidone palmitate in schizophrenia, sponsored by University of California, Los Angeles. Started Oct 2011; status: completed.
02
Drugs
paliperidone palmitate
03
Conditions
schizophrenia
Beyond the preview
Go deeper on NCT01451736.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT01451736.